American Factories Lag in Adopting A.I. This Drugmaker Is an Exception.

In a sterile Bristol Myers Squibb lab about an hour north of Boston, scientists in scrubs and hairnets transfer living cells to a 2,000-liter stainless steel bioreactor that grows them for weeks. The goal is to produce proteins that are genetically engineered to attack cells that cause disease. Tiny variations in heat, light or pH level can stop the cells from growing, causing drug shortages that endanger patients. Typically scientists would have to wait to see what went wrong during that fragile process, but now artificial intelligence is used to…

Your Wednesday Evening Briefing

(Want to get this newsletter in your inbox? Here’s the sign-up.) Good evening. Here’s the latest at the end of Wednesday. 1. Voter fraud prosecution is rare, erratic and often undeserved. As part of our Democracy Challenged series, The New York Times reviewed some 400 voting-fraud charges filed since 2017. Often, voters didn’t know they’d broken a law. Serious penalties usually fell hardest on those least able to fight back: Poor and Black people were likelier to go to jail than comfortable retirees. In Florida, where the governor, Ron DeSantis,…